Programmed cell death 5 improves skeletal muscle insulin resistance by inhibiting IRS-1 ubiquitination through

Bo Li1, Jingjing Ye2, Ruxia Liu1

  • 1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R. China.

Life Sciences
|September 4, 2021
PubMed
Abstract

Insights

Programmed cell death 5 (PDCD5) protects against skeletal muscle insulin resistance by stabilizing IRS-1. Upregulated PDCD5 early in insulin resistance prevents IRS-1 degradation, offering a therapeutic target for metabolic syndrome.

Area of Science:

  • Molecular Biology
  • Metabolic Diseases
  • Cellular Signaling

Background:

  • Insulin resistance, a hallmark of metabolic syndrome, involves decreased tissue sensitivity to insulin.
  • The role of Programmed cell death 5 (PDCD5) in insulin resistance, particularly in skeletal muscle, remains largely uncharacterized.
  • Skeletal muscle is a primary insulin target organ, making its response to insulin crucial for metabolic homeostasis.

Purpose of the Study:

  • To investigate the function of PDCD5 in skeletal muscle insulin resistance.
  • To elucidate the underlying molecular mechanisms by which PDCD5 influences insulin signaling pathways.

Main Methods:

  • High-fat diet-induced obesity model in mice.
  • Palmitate treatment of C2C12 myotubes to mimic insulin resistance.
  • Gain-of-function and loss-of-function studies using PDCD5 overexpression and knockdown in C2C12 cells.

Main Results:

  • PDCD5 levels initially increase then decrease in skeletal muscle of obese mice and insulin-resistant myotubes.
  • PDCD5 overexpression protected against palmitate-induced insulin resistance; PDCD5 knockdown exacerbated it.
  • PDCD5 interacts with MDM2, reducing MDM2 levels and inhibiting palmitate-induced IRS-1 ubiquitination and degradation.

Conclusions:

  • PDCD5 is upregulated early in skeletal muscle insulin resistance.
  • PDCD5 enhances insulin sensitivity by interacting with MDM2, thereby stabilizing IRS-1.
  • PDCD5 exhibits a protective role against insulin resistance in skeletal muscle.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K